Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Outskill Gea AI
    Outskill Gea AI
    HomeNewsBusinessEarningsBuy Sun Pharmaceutical Industries: target of Rs 900: Sharekhan

    Buy Sun Pharmaceutical Industries: target of Rs 900: Sharekhan

    Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 900 in its research report dated July 30, 2021.

    Broker Research
    August 02, 2021 / 13:50 IST
    An Edelweiss research report for Q4FY21 says road tonnage continued to improve, evident in e-way bill generation (up 6% QoQ) and improved core trucking rentals. “We estimate tonnage would increase by three–five percent for truckers. Asset-light plays Mahindra Logistics and TCI Express remain our preferred picks due to their ability to scale up/down as the environment demands,” the report said. Edelweiss is bullish on Blue Dart Express due to the pandemic-induced boom in e-commerce and its leaner cost structure. It has retained a ‘buy’ call on Mahindra Logistics, TCI Express and Blue Dart Express.
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More
      Sharekhan's research report on Sun Pharmaceutical Industries

      Sun Pharma’s Q1FY2022 results were strong driven by an impressive performance from the India, RoW and US businesses. A strong growth in chronic therapies, including the sub chronics along with new product launches would fuel growth in the domestic formulations business. Growth in the US business would be driven by a pick-up in specialty business coupled with traction from new product launches coupled with geographic expansion / increasing penetration.

      Outlook

      Improved growth prospects across business and full resolution of all matters by the Department of Justice antitrust and civil division in the US generic markets would be key positives. we retain Buy recommendation with a revised PT of Rs. 900.

      For all recommendations report, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

      Read More Read More

      Broker Research
      first published: Aug 2, 2021 01:08 pm

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
      CloseGen AI Masterclass